BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29508423)

  • 1. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
    Walker GJ; Moore L; Heerasing N; Hendy P; Perry MH; McDonald TJ; Debenham T; Bethune R; Bewshea C; Hyde C; Heap GA; Singh A; Calvert C; Kennedy NA; Goodhand JR; Ahmad T
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1103-1116. PubMed ID: 29508423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
    Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
    Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
    Holtman GA; Lisman-van Leeuwen Y; van Rheenen PF; Kollen BJ; Escher JC; Kindermann A; de Rijke YB; Berger MY
    Fam Pract; 2017 Aug; 34(4):400-406. PubMed ID: 27535331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
    Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
    Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
    Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
    J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
    Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
    Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.
    Kennedy NA; Clark A; Walkden A; Chang JC; Fascí-Spurio F; Muscat M; Gordon BW; Kingstone K; Satsangi J; Arnott ID; Lees CW
    J Crohns Colitis; 2015 Jan; 9(1):41-9. PubMed ID: 25135754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
    Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
    Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
    McFarlane M; Chambers S; Malik A; Lee B; Sung E; Nwokolo C; Waugh N; Arasaradnam R
    BMJ Open; 2016 Jun; 6(6):e011041. PubMed ID: 27266773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
    Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
    Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Fecal Calprotectin in Evaluation of Chronic Gastrointestinal Symptoms in Primary Care.
    Ramraj R; Garcia A; Mosen D; Waiwaiole L; Smith N
    Clin Pediatr (Phila); 2018 Aug; 57(9):1058-1063. PubMed ID: 29192504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care.
    Pavlidis P; Chedgy FJ; Tibble JA
    Scand J Gastroenterol; 2013 Sep; 48(9):1048-54. PubMed ID: 23883068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study.
    Kok L; Elias SG; Witteman BJ; Goedhard JG; Muris JW; Moons KG; de Wit NJ
    Clin Chem; 2012 Jun; 58(6):989-98. PubMed ID: 22407858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis.
    van Rheenen PF; Van de Vijver E; Fidler V
    BMJ; 2010 Jul; 341():c3369. PubMed ID: 20634346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease.
    Zhang W; Wong CH; Chavannes M; Mohammadi T; Rosenfeld G
    BMJ Open; 2019 Apr; 9(4):e027043. PubMed ID: 30987989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal calprotectin in the diagnosis of inflammatory bowel disease.
    Burri E; Beglinger C
    Biochem Med (Zagreb); 2011; 21(3):245-53. PubMed ID: 22420238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the IMRD-UK data.
    Freeman K; Taylor-Phillips S; Willis BH; Ryan R; Clarke A
    BMJ Open; 2021 Feb; 11(2):e044177. PubMed ID: 33619196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.
    An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J
    Med J Aust; 2019 Nov; 211(10):461-467. PubMed ID: 31680263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a faecal calprotectin care pathway for use in primary care.
    Turvill J; O'Connell S; Brooks A; Bradley-Wood K; Laing J; Thiagarajan S; Hammond D; Turnock D; Jones A; Sood R; Ford A
    Prim Health Care Res Dev; 2016 Sep; 17(5):428-36. PubMed ID: 26899214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.